MIBG With Dinutuximab +/- Vorinostat

NCT03332667 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

45

Enrollment

OTHER

Sponsor class

Conditions

Neuroblastoma

Interventions

RADIATION: 131I-MIBG
DRUG: Dinutuximab
DRUG: Vorinostat
DRUG: Sargramostim
DRUG: Potassium Iodide

Sponsor

New Approaches to Neuroblastoma Therapy Consortium

Collaborators

[object Object]
[object Object]